Royalty Report: Medical, Supply, Orthopedic – Collection: 89713


Curated Royalty Rate Report
Category: Technology Licenses, Created On: 2022-04-28, Record Count: 3


This collection of transactions and supporting information was developed using our AI algorithm to curate similar royalty reports into a cohesive collection to support your licensing, transfer pricing or other transaction scenarios where documented royalty rates and/or deal terms are important.
Category: Technology Licenses
Created On: 2022-04-28
Record Count: 3

Primary Industries

  • Medical
  • Supply
  • Orthopedic

IPSCIO Report Record List

Below you will find the records curated into this collection.  This summary includes the complete licensed property description so that you can review and determine if this collection covers the topics, technology or transaction type that is relevant for your needs.  The full report will include all relevant deal data such as the royalty base, agreement date, term description, royalty rates and other deal terms.  For reference, here is a sample of a full IPSCIO curated royalty rate report: Sample Report

IPSCIO Record ID: 89713

License Grant
The Company assumed an exclusive world-wide, royalty bearing license, as well as the right to sublicense, for the use of certain developed technologies related to spine repair with an undisclosed Licensee.
License Property
Bioactive glass is a group of synthetic silicate-based materials, characterized by their bioactivity and their unique bone-bonding properties. Bioactive glass is composed mainly of silica, sodium oxide, calcium oxide and phosphates. The bone-bonding reaction results from a sequence of reactions in the glass and its surface.
Field of Use
This agreement pertains to the medical industry related to spine repair for the treatment of patients suffering from a broad array of musculoskeletal conditions.

IPSCIO Record ID: 226071

License Grant
The Company assumed an exclusive license agreement with an undisclosed Licensee for bioactive bone graft putty.
License Property
Bioactive bone graft putty is an FDA cleared bioactive synthetic bone graft substitute comprised of a mixture of calcium phosphate granules and bioglass granules suspended in a resorbable polymer carrier that facilitates handling and delivery of the granule components to fill spaces of missing bone. The product is indicated as a bone void filler for standalone use in posterolateral spine fusion procedures without the aid of autologous extenders or enhancers to meet the needs of the surgeon and effectively facilitate structural fusion of the spine. The ratio of certain components in Signafuse’s composition is similar to ratios found to promote attachment and bone formation to produce a stable scaffold that allows sustained bioactivity and osteoconductivity during the healing process. The patented bioactive component is designed for a faster rate of bone fill than bioglass particles with a broader size range. In vitro studies have demonstrated the product’s effective phosphate layer formation on the surface of the implant as early as seven days after application.

IPSCIO Record ID: 253964

License Grant
The Parties desire to develop and commercialize an Additional Product, as a product line extension of Licensees proprietary synthetic bioactive bone grafting material known as VITOSS.

The Parties designate BioActive VITOSS FOAM as an Initial Product.

The original agreement is exclusive.

License Property
Initial Products shall mean any one or combination of Hot Pockets  comprised of Licensees VITOSS product wrapped or otherwise incorporated in porous, bioresorbable material developed by Licensor; bioresorbable dough based on Licensees VITOSS in combination with other resorbable materials developed by Licensor;  bioresorbable haste based on Licensees VITOSS in combination with other resorbable materials developed by Licensor;  CorticoCancellous Products; and  BioActive VITOSS FOAM, in each case utilizing the respective Intellectual Property of both Parties, and as developed and manufactured by the parties pursuant to this Agreement.

'BioActive VITOSS FOAM' shall mean VITOSS, combined with BioActive Ceramic Material and fibrous bovine collagen.'

Field of Use
The field of use is synthetic bioactive bone grafting.
Disclaimer: The information gathered from RoyaltySource® database was sourced from the U.S. Securities and Exchange Commission EDGAR Filings and other public records. While we believe the sources to be reliable, this does not guarantee the accuracy or completeness of the information provided. Further, the information is supplied as general guidance and is not intended to represent or be a substitute for a detailed analysis or professional judgment. This information is for private use only and may not be resold or reproduced without permission.